Orgenesis Inc. Cost of Revenue

Cost of Revenue of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cost of Revenue growth rates and interactive chart. Cost of revenue refers to the direct costs attributable to the production of the goods or supply of services by an entity. It is also commonly known as the “cost of goods sold (COGS)”. Cost of sales measures the cost of goods produced or services provided in a period by an entity. It includes the cost of the direct materials used in producing the goods, direct labor costs used to produce the good, along with any other direct costs associated with the production of goods. In case of services cost of sales includes the labor cost or salaries of the employees and other directly attributable costs. Cost of sales does not include indirect expenses such as distribution costs and marketing costs. It appears on the income statement and is deducted from the sales revenue for the calculation of gross profit (or gross margin).


Highlights and Quick Summary

  • Cost of Revenue for the quarter ending September 29, 2021 was $10 Million (a 2.88% increase compared to previous quarter)
  • Year-over-year quarterly Cost of Revenue decreased by -78.8%
  • Annual Cost of Revenue for 2020 was $84 Million (a 499.3% increase from previous year)
  • Annual Cost of Revenue for 2019 was $14 Million (a 7.33% increase from previous year)
  • Annual Cost of Revenue for 2018 was $13.1 Million (a 20.63% increase from previous year)
  • Twelve month Cost of Revenue ending September 29, 2021 was $73.1 Million (a 4.37% increase compared to previous quarter)
  • Twelve month trailing Cost of Revenue decreased by -13.01% year-over-year
Trailing Cost of Revenue for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
$73.1 Million $70 Million $85.2 Million $84 Million
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cost of Revenue of Orgenesis Inc.

Most recent Cost of Revenueof ORGS including historical data for past 10 years.

Interactive Chart of Cost of Revenue of Orgenesis Inc.

Orgenesis Inc. Cost of Revenue for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $10.01 $9.73 $6.13
2020 $47.2 $6.95 $24.96 $4.87 $83.99
2019 $2.82 $2.51 $3.08 $5.61 $14.01
2018 $4.83 $3.38 $2.2 $1.64 $13.06
2017 $1.87 $1.13 $1.91 $8.55
2016 $1.91 $1.83 $1.96 $1.96 $9.28
2015 $3.88

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.